Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake

• Tilman Läppchen,

  Affiliations Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, Department of Nuclear Medicine, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland

  ⨯
• Roswitha Tönnesmann,

  Affiliation Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Germany

  ⨯
• Jos Eersels,

  Affiliation Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands

  ⨯
• Philipp T. Meyer,

  Affiliations Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany

  ⨯
• Helmut R. Maecke,

  Affiliations Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany

  ⨯
• Svetlana N. Rylova

  * E-mail: svetlana.rylova@uniklinik-freiburg.de

  Affiliations Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯